MIT engineers have developed an adjustable gastric balloon for weight loss that can be inflated or deflated to help avoid the plateauing effect of traditional gastric balloons.

Over half the adult U.S. population may become eligible for a new anti-obesity drug, semaglutide, with implications for those with diabetes and heart issues.

Recent research links prolonged sitting to an increased risk of heart disease, even with regular exercise, suggesting a need for continuous movement throughout the day.

A study found a decline in bariatric surgeries amid a rise in anti-obesity drug use among privately insured adults, with calls for improved obesity treatment access.

An MIT study found that for-profit hospice care reduces Medicare costs by about $29,000 per ADRD patient over five years, raising questions about current Medicare policies.

Harvard scientists are working on new methods to speed up depression treatment, aiming to reduce the current lengthy trial-and-error process of finding effective medication.

Mass General Brigham postpones elective surgeries due to a shortage of IV fluids after flood damage to a key supplier's plant following Hurricane Helene.

Four Northeastern University grad students have chickenpox, prompting a health alert. They're isolated and treated, with the campus urged to check immunization records.

Recent research indicates falls significantly increase the risk of dementia in older adults, suggesting urgent need for cognitive screenings post-fall.

Massachusetts healthcare sees five Steward Health Care hospitals shift to local operators, with state officials emphasizing patient care and job preservation.

A study suggests "weekend warriors" who condense weekly exercise into one or two days gain similar health benefits as those who spread it out, potentially reducing the risk of 264 diseases.

Harvard scientists developed a drug-free nasal spray that could help prevent respiratory illnesses by trapping and deactivating pathogens, showing promise in lab and animal tests.

Harvard experts criticize the exploitation of weight loss trends by companies offering scientifically unsupported products, noting the potential public health risks and the perpetuation of obesity stigma.